APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-helminthic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-helminthic Drugs Market Analysis and Forecast 2026-2032

Report ID 173964890227 December 2025201 pages

Choose your research edition.

Industry ResearchAnti-helminthic Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-helminthic Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Anti-helminthic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-helminthic Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-helminthic Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Anti-helminthic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-helminthic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-helminthic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-helminthic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-helminthic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti-helminthic Drugs include Anhui Shengying Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. and Jiaozuo Furuitang Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-helminthic Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-helminthic Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-helminthic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-helminthic Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-helminthic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-helminthic Drugs sales, projected growth trends, production technology, application and end-user industry.

Anti-helminthic Drugs Segment by Company

Anhui Shengying Pharmaceutical Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Chengdu Hengda Pharmaceutical Co., Ltd.

Diao Group Chengdu Pharmaceutical Co., Ltd.

Fujian Dongrui Pharmaceutical Co., Ltd.

Guilin Nanyao Pharmaceutical Co., Ltd.

Hubei Ruihua Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Jiaozuo Furuitang Pharmaceutical Co., Ltd.

Nanjing Pharmaceutical Factory Co., Ltd.

Shaanxi Hanwang Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Shanghai Tengrui Pharmaceutical Co., Ltd.

Shaoxing Minsheng Pharmaceutical Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Zhejiang Anbet Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

Anti-helminthic Drugs Segment by Type

Pyrantel Pamoate

Piperazine

Mimbendazole

Praziquantel

Albendazole

Anti-helminthic Drugs Segment by Application

For Veterinary Use

For Human Use

Anti-helminthic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-helminthic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-helminthic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-helminthic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti-helminthic Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti-helminthic Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-helminthic Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-helminthic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pyrantel Pamoate Major Manufacturers Table 3. Piperazine Major Manufacturers Table 4. Mimbendazole Major Manufacturers Table 5. Praziquantel Major Manufacturers Table 6. Albendazole Major Manufacturers Table 7. Global Anti-helminthic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. For Veterinary Use Major Manufacturers Table 9. For Human Use Major Manufacturers Table 10. Anti-helminthic Drugs Industry Trends Table 11. Anti-helminthic Drugs Industry Drivers Table 12. Anti-helminthic Drugs Industry Opportunities and Challenges Table 13. Anti-helminthic Drugs Industry Restraints Table 14. Global Anti-helminthic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Anti-helminthic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Anti-helminthic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Anti-helminthic Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Anti-helminthic Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Anti-helminthic Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Anti-helminthic Drugs Sales by Region (2021-2026) & (K Units) Table 21. Global Anti-helminthic Drugs Sales by Region (2027-2032) & (K Units) Table 22. Global Anti-helminthic Drugs Sales Market Share by Region (2021-2026) Table 23. Global Anti-helminthic Drugs Sales Market Share by Region (2027-2032) Table 24. Global Anti-helminthic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Anti-helminthic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Anti-helminthic Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Anti-helminthic Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Anti-helminthic Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Anti-helminthic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Anti-helminthic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Anti-helminthic Drugs Manufacturers, Product Type & Application Table 32. Global Anti-helminthic Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Anti-helminthic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Anti-helminthic Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Anti-helminthic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Anti-helminthic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Anti-helminthic Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Anti-helminthic Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 42. Global Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units) Table 43. Global Anti-helminthic Drugs Sales Market Share by Type (2021-2026) Table 44. Global Anti-helminthic Drugs Sales Market Share by Type (2027-2032) Table 45. Global Anti-helminthic Drugs Price by Type (2021-2026) & (US$/Unit) Table 46. Global Anti-helminthic Drugs Price by Type (2027-2032) & (US$/Unit) Table 47. Global Anti-helminthic Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Anti-helminthic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Anti-helminthic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Anti-helminthic Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Anti-helminthic Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units) Table 55. Global Anti-helminthic Drugs Sales Market Share by Application (2021-2026) Table 56. Global Anti-helminthic Drugs Sales Market Share by Application (2027-2032) Table 57. Global Anti-helminthic Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Anti-helminthic Drugs Price by Application (2027-2032) & (US$/Unit) Table 59. Anhui Shengying Pharmaceutical Co., Ltd. Company Information Table 60. Anhui Shengying Pharmaceutical Co., Ltd. Business Overview Table 61. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 63. Anhui Shengying Pharmaceutical Co., Ltd. Recent Development Table 64. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 65. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 66. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 68. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development Table 69. Chengdu Hengda Pharmaceutical Co., Ltd. Company Information Table 70. Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview Table 71. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 73. Chengdu Hengda Pharmaceutical Co., Ltd. Recent Development Table 74. Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information Table 75. Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview Table 76. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 78. Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Development Table 79. Fujian Dongrui Pharmaceutical Co., Ltd. Company Information Table 80. Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview Table 81. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 83. Fujian Dongrui Pharmaceutical Co., Ltd. Recent Development Table 84. Guilin Nanyao Pharmaceutical Co., Ltd. Company Information Table 85. Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview Table 86. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 88. Guilin Nanyao Pharmaceutical Co., Ltd. Recent Development Table 89. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information Table 90. Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview Table 91. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 93. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Development Table 94. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information Table 95. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview Table 96. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 98. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Development Table 99. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information Table 100. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview Table 101. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 103. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Development Table 104. Nanjing Pharmaceutical Factory Co., Ltd. Company Information Table 105. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview Table 106. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 108. Nanjing Pharmaceutical Factory Co., Ltd. Recent Development Table 109. Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information Table 110. Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview Table 111. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 113. Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Development Table 114. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information Table 115. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview Table 116. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 118. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Development Table 119. Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information Table 120. Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview Table 121. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 123. Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Development Table 124. Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information Table 125. Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview Table 126. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 128. Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Development Table 129. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information Table 130. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview Table 131. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 133. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Development Table 134. Southwest Pharmaceutical Co., Ltd. Company Information Table 135. Southwest Pharmaceutical Co., Ltd. Business Overview Table 136. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 138. Southwest Pharmaceutical Co., Ltd. Recent Development Table 139. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information Table 140. Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview Table 141. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 143. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Development Table 144. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 145. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 146. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 148. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 149. North America Anti-helminthic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 150. North America Anti-helminthic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 151. North America Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 152. North America Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units) Table 153. North America Anti-helminthic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 154. North America Anti-helminthic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 155. North America Anti-helminthic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 156. North America Anti-helminthic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 157. North America Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 158. North America Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units) Table 159. North America Anti-helminthic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 160. North America Anti-helminthic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 161. North America Anti-helminthic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. North America Anti-helminthic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. North America Anti-helminthic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. North America Anti-helminthic Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. North America Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 166. North America Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 167. North America Anti-helminthic Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 168. North America Anti-helminthic Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 169. United States Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 170. Canada Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 171. Mexico Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 172. Europe Anti-helminthic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 173. Europe Anti-helminthic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 174. Europe Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 175. Europe Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units) Table 176. Europe Anti-helminthic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Europe Anti-helminthic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Europe Anti-helminthic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Anti-helminthic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 181. Europe Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units) Table 182. Europe Anti-helminthic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Europe Anti-helminthic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Europe Anti-helminthic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Europe Anti-helminthic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Europe Anti-helminthic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Europe Anti-helminthic Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Europe Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 189. Europe Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 190. Europe Anti-helminthic Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Europe Anti-helminthic Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Germany Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 193. France Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 194. U.K. Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 195. Italy Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 196. Russia Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 197. Spain Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 198. Netherlands Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 199. Switzerland Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 200. Sweden Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 201. Poland Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 202. China Anti-helminthic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 203. China Anti-helminthic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 204. China Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 205. China Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units) Table 206. China Anti-helminthic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 207. China Anti-helminthic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 208. China Anti-helminthic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 209. China Anti-helminthic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 210. China Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 211. China Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units) Table 212. China Anti-helminthic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 213. China Anti-helminthic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 214. Asia Anti-helminthic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 215. Asia Anti-helminthic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 216. Asia Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 217. Asia Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units) Table 218. Asia Anti-helminthic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 219. Asia Anti-helminthic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 220. Asia Anti-helminthic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 221. Asia Anti-helminthic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 222. Asia Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 223. Asia Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units) Table 224. Asia Anti-helminthic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 225. Asia Anti-helminthic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 226. Asia Anti-helminthic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. Asia Anti-helminthic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. Asia Anti-helminthic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. Asia Anti-helminthic Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 230. Asia Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 231. Asia Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 232. Asia Anti-helminthic Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 233. Asia Anti-helminthic Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 234. Japan Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 235. South Korea Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 236. India Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 237. Australia Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 238. Taiwan Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 239. Southeast Asia Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 240. SAMEA Anti-helminthic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 241. SAMEA Anti-helminthic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 242. SAMEA Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 243. SAMEA Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units) Table 244. SAMEA Anti-helminthic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 245. SAMEA Anti-helminthic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 246. SAMEA Anti-helminthic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 247. SAMEA Anti-helminthic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 248. SAMEA Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 249. SAMEA Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units) Table 250. SAMEA Anti-helminthic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 251. SAMEA Anti-helminthic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 252. SAMEA Anti-helminthic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 253. SAMEA Anti-helminthic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 254. SAMEA Anti-helminthic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 255. SAMEA Anti-helminthic Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 256. SAMEA Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 257. SAMEA Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 258. SAMEA Anti-helminthic Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 259. SAMEA Anti-helminthic Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 260. Brazil Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 261. Argentina Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 262. Chile Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 263. Colombia Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 264. Peru Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 265. Saudi Arabia Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 266. Israel Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 267. UAE Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 268. Turkey Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 269. Iran Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 270. Egypt Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Table 271. Key Raw Materials Table 272. Raw Materials Key Suppliers Table 273. Anti-helminthic Drugs Distributors List Table 274. Anti-helminthic Drugs Customers List Table 275. Research Programs/Design for This Report Table 276. Authors List of This Report Table 277. Secondary Sources Table 278. Primary Sources List of Figures Figure 1. Anti-helminthic Drugs Image Figure 2. Global Anti-helminthic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-helminthic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pyrantel Pamoate Image Figure 5. Piperazine Image Figure 6. Mimbendazole Image Figure 7. Praziquantel Image Figure 8. Albendazole Image Figure 9. Global Anti-helminthic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Anti-helminthic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. For Veterinary Use Image Figure 12. For Human Use Image Figure 13. Global Anti-helminthic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Anti-helminthic Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Anti-helminthic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Anti-helminthic Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Anti-helminthic Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Anti-helminthic Drugs Sales (2021-2032) & (K Units) Figure 19. Global Anti-helminthic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Anti-helminthic Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Anti-helminthic Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Europe Anti-helminthic Drugs Sales YoY (2021-2032) & (K Units) Figure 23. China Anti-helminthic Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Anti-helminthic Drugs Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Anti-helminthic Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Global Anti-helminthic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Anti-helminthic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Anti-helminthic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Anti-helminthic Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Anti-helminthic Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Anti-helminthic Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Anti-helminthic Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Anti-helminthic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Anti-helminthic Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Anti-helminthic Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Anti-helminthic Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Anti-helminthic Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Anti-helminthic Drugs Revenue Share by Type (2021-2032) Figure 42. North America Anti-helminthic Drugs Sales Share by Type (2021-2032) Figure 43. North America Anti-helminthic Drugs Revenue Share by Application (2021-2032) Figure 44. North America Anti-helminthic Drugs Sales Share by Application (2021-2032) Figure 45. North America Anti-helminthic Drugs Revenue Share by Country (2021-2032) Figure 46. North America Anti-helminthic Drugs Sales Share by Country (2021-2032) Figure 47. Europe Anti-helminthic Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Anti-helminthic Drugs Sales Share by Type (2021-2032) Figure 49. Europe Anti-helminthic Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Anti-helminthic Drugs Sales Share by Application (2021-2032) Figure 51. Europe Anti-helminthic Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Anti-helminthic Drugs Sales Share by Country (2021-2032) Figure 53. China Anti-helminthic Drugs Revenue Share by Type (2021-2032) Figure 54. China Anti-helminthic Drugs Sales Share by Type (2021-2032) Figure 55. China Anti-helminthic Drugs Revenue Share by Application (2021-2032) Figure 56. China Anti-helminthic Drugs Sales Share by Application (2021-2032) Figure 57. Asia Anti-helminthic Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Anti-helminthic Drugs Sales Share by Type (2021-2032) Figure 59. Asia Anti-helminthic Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Anti-helminthic Drugs Sales Share by Application (2021-2032) Figure 61. Asia Anti-helminthic Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Anti-helminthic Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Anti-helminthic Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Anti-helminthic Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Anti-helminthic Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Anti-helminthic Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Anti-helminthic Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Anti-helminthic Drugs Sales Share by Country (2021-2032) Figure 69. Anti-helminthic Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Anti-helminthic Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Pyrantel Pamoate
  • Piperazine
  • Mimbendazole
  • Praziquantel
  • Albendazole
Applications
  • For Veterinary Use
  • For Human Use
Companies covered
  • Anhui Shengying Pharmaceutical Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Chengdu Hengda Pharmaceutical Co., Ltd.
  • Diao Group Chengdu Pharmaceutical Co., Ltd.
  • Fujian Dongrui Pharmaceutical Co., Ltd.
  • Guilin Nanyao Pharmaceutical Co., Ltd.
  • Hubei Ruihua Pharmaceutical Co., Ltd.
  • China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  • Jiaozuo Furuitang Pharmaceutical Co., Ltd.
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Shaanxi Hanwang Pharmaceutical Co., Ltd.
  • Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  • Shanghai Tengrui Pharmaceutical Co., Ltd.
  • Shaoxing Minsheng Pharmaceutical Co., Ltd.
  • Sichuan Tiande Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Zhejiang Anbet Pharmaceutical Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-helminthic Drugs Market by Type
  3. 1.2.1 Global Anti-helminthic Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pyrantel Pamoate
  5. 1.2.3 Piperazine
  6. 1.2.4 Mimbendazole
  7. 1.2.5 Praziquantel
  8. 1.2.6 Albendazole
  9. 1.3 Anti-helminthic Drugs Market by Application
  10. 1.3.1 Global Anti-helminthic Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 For Veterinary Use
  12. 1.3.3 For Human Use
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Anti-helminthic Drugs Market Dynamics
  1. 2.1 Anti-helminthic Drugs Industry Trends
  2. 2.2 Anti-helminthic Drugs Industry Drivers
  3. 2.3 Anti-helminthic Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-helminthic Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti-helminthic Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti-helminthic Drugs Revenue by Region
  3. 3.2.1 Global Anti-helminthic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-helminthic Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti-helminthic Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti-helminthic Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti-helminthic Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti-helminthic Drugs Sales by Region
  9. 3.4.1 Global Anti-helminthic Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti-helminthic Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Anti-helminthic Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Anti-helminthic Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti-helminthic Drugs Revenue by Manufacturers
  2. 4.1.1 Global Anti-helminthic Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti-helminthic Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti-helminthic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-helminthic Drugs Sales by Manufacturers
  6. 4.2.1 Global Anti-helminthic Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti-helminthic Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti-helminthic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti-helminthic Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti-helminthic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti-helminthic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti-helminthic Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Anti-helminthic Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti-helminthic Drugs Market CR5 and HHI
  16. 4.8.2 2025 Anti-helminthic Drugs Tier 1, Tier 2, and Tier 3
5 Anti-helminthic Drugs Market by Type
  1. 5.1 Global Anti-helminthic Drugs Revenue by Type
  2. 5.1.1 Global Anti-helminthic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti-helminthic Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti-helminthic Drugs Sales by Type
  6. 5.2.1 Global Anti-helminthic Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-helminthic Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Anti-helminthic Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti-helminthic Drugs Price by Type
6 Anti-helminthic Drugs Market by Application
  1. 6.1 Global Anti-helminthic Drugs Revenue by Application
  2. 6.1.1 Global Anti-helminthic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti-helminthic Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti-helminthic Drugs Sales by Application
  6. 6.2.1 Global Anti-helminthic Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti-helminthic Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Anti-helminthic Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti-helminthic Drugs Price by Application
7 Company Profiles
  1. 7.1 Anhui Shengying Pharmaceutical Co., Ltd.
  2. 7.1.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  6. 7.1.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Beijing Taiyang Pharmaceutical Co., Ltd.
  8. 7.2.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  12. 7.2.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Chengdu Hengda Pharmaceutical Co., Ltd.
  14. 7.3.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  18. 7.3.5 Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Diao Group Chengdu Pharmaceutical Co., Ltd.
  20. 7.4.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  24. 7.4.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Fujian Dongrui Pharmaceutical Co., Ltd.
  26. 7.5.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  30. 7.5.5 Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Guilin Nanyao Pharmaceutical Co., Ltd.
  32. 7.6.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  36. 7.6.5 Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Hubei Ruihua Pharmaceutical Co., Ltd.
  38. 7.7.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  42. 7.7.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  44. 7.8.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  48. 7.8.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Jiaozuo Furuitang Pharmaceutical Co., Ltd.
  50. 7.9.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
  51. 7.9.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview
  52. 7.9.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  54. 7.9.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments
  55. 7.10 Nanjing Pharmaceutical Factory Co., Ltd.
  56. 7.10.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
  57. 7.10.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
  58. 7.10.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio
  60. 7.10.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 7.11 Shaanxi Hanwang Pharmaceutical Co., Ltd.
  62. 7.11.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  66. 7.11.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  68. 7.12.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  72. 7.12.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Shanghai Tengrui Pharmaceutical Co., Ltd.
  74. 7.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
  75. 7.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview
  76. 7.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  78. 7.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments
  79. 7.14 Shaoxing Minsheng Pharmaceutical Co., Ltd.
  80. 7.14.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
  81. 7.14.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview
  82. 7.14.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  84. 7.14.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments
  85. 7.15 Sichuan Tiande Pharmaceutical Co., Ltd.
  86. 7.15.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
  87. 7.15.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
  88. 7.15.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  90. 7.15.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
  91. 7.16 Southwest Pharmaceutical Co., Ltd.
  92. 7.16.1 Southwest Pharmaceutical Co., Ltd. Company Information
  93. 7.16.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  94. 7.16.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  96. 7.16.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  97. 7.17 Zhejiang Anbet Pharmaceutical Co., Ltd.
  98. 7.17.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
  99. 7.17.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
  100. 7.17.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  102. 7.17.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
  103. 7.18 Zhejiang Hisun Pharmaceutical Co., Ltd.
  104. 7.18.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  105. 7.18.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  106. 7.18.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  108. 7.18.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Anti-helminthic Drugs Market Size by Type
  2. 8.1.1 North America Anti-helminthic Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti-helminthic Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Anti-helminthic Drugs Price by Type (2021-2032)
  5. 8.2 North America Anti-helminthic Drugs Market Size by Application
  6. 8.2.1 North America Anti-helminthic Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti-helminthic Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Anti-helminthic Drugs Price by Application (2021-2032)
  9. 8.3 North America Anti-helminthic Drugs Market Size by Country
  10. 8.3.1 North America Anti-helminthic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti-helminthic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti-helminthic Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Anti-helminthic Drugs Market Size by Type
  2. 9.1.1 Europe Anti-helminthic Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti-helminthic Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti-helminthic Drugs Price by Type (2021-2032)
  5. 9.2 Europe Anti-helminthic Drugs Market Size by Application
  6. 9.2.1 Europe Anti-helminthic Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti-helminthic Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti-helminthic Drugs Price by Application (2021-2032)
  9. 9.3 Europe Anti-helminthic Drugs Market Size by Country
  10. 9.3.1 Europe Anti-helminthic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti-helminthic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti-helminthic Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Anti-helminthic Drugs Market Size by Type
  2. 10.1.1 China Anti-helminthic Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Anti-helminthic Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Anti-helminthic Drugs Price by Type (2021-2032)
  5. 10.2 China Anti-helminthic Drugs Market Size by Application
  6. 10.2.1 China Anti-helminthic Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Anti-helminthic Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Anti-helminthic Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-helminthic Drugs Market Size by Type
  2. 11.1.1 Asia Anti-helminthic Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti-helminthic Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti-helminthic Drugs Price by Type (2021-2032)
  5. 11.2 Asia Anti-helminthic Drugs Market Size by Application
  6. 11.2.1 Asia Anti-helminthic Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti-helminthic Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti-helminthic Drugs Price by Application (2021-2032)
  9. 11.3 Asia Anti-helminthic Drugs Market Size by Country
  10. 11.3.1 Asia Anti-helminthic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti-helminthic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti-helminthic Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-helminthic Drugs Market Size by Type
  2. 12.1.1 SAMEA Anti-helminthic Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti-helminthic Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti-helminthic Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Anti-helminthic Drugs Market Size by Application
  6. 12.2.1 SAMEA Anti-helminthic Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti-helminthic Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti-helminthic Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Anti-helminthic Drugs Market Size by Country
  10. 12.3.1 SAMEA Anti-helminthic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti-helminthic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti-helminthic Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti-helminthic Drugs Value Chain Analysis
  2. 13.1.1 Anti-helminthic Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti-helminthic Drugs Production Mode & Process
  6. 13.2 Anti-helminthic Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti-helminthic Drugs Distributors
  9. 13.2.3 Anti-helminthic Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst